{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-000199","form_type":"8-K","ticker":"FHTX","cik":"0001822462","company_name":"Foghorn Therapeutics Inc.","filed_at":"2024-01-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.741832+00:00","generated_at":"2026-06-07T04:47:17.968500+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Foghorn Therapeutics CFO Allan Reine resigns effective Jan 16, 2024","bullets":["CFO Allan Reine resigns to pursue other opportunity; effective Jan 16, 2024.","Departure not due to any disagreement with company's operations, policies, or financial controls.","Company has commenced formal search for a successor; CEO thanked Reine for his leadership.","Dr. Reine's last full-time day will be January 16, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-000199","json":"https://secwatch.observer/filing/0001628280-24-000199.json","markdown":"https://secwatch.observer/filing/0001628280-24-000199.md","text":"https://secwatch.observer/filing/0001628280-24-000199.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822462/000162828024000199/0001628280-24-000199-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822462/000162828024000199/fhtx-20231229.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T04:47:17.968500+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ab50e5c8d2","claim":"Allan Reine resigned as Chief Financial Officer at Foghorn Therapeutics Inc..","evidence_excerpt":"Allan Reine, M.D. notified Foghorn Therapeutics Inc. (the \"Company\") of his decision to resign as Chief Financial Officer, effective January 16, 2024, to pursue other opportunities.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822462/000162828024000199/0001628280-24-000199-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}